Prospective Evaluation of Open-Angle Glaucoma Subjects on One Topical Hypotensive Medication Treated With Two iStents

NCT01252862 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

40

Enrollment

INDUSTRY

Sponsor class

Conditions

Subjects With Primary Open-angle Glaucoma (POAG)

Interventions

DEVICE: iStent

Sponsor

Glaukos Corporation